Link to this page
Medical Subject Headings
Last uploaded:
January 16, 2025
Jump to:
| Id | http://purl.bioontology.org/ontology/MESH/D004077
http://purl.bioontology.org/ontology/MESH/D004077
|
|---|---|
| Preferred Name | Digoxin |
| Definitions |
A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
|
| Synonyms |
Lanoxin
Hemigoxine Nativelle
Dilanacin
Lanoxin PG
Lanoxicaps
Digacin
Nativelle, Hemigoxine
Lanacordin
Lenoxin
Boehringer, Digoxina
Digoxina Boehringer
Lanoxin-PG
Lanicor
Mapluxin
Digoxine Nativelle
Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
Digoregen
Nativelle, Digoxine
Digitek
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) |
|---|---|
| altLabel |
Lanoxin
Hemigoxine Nativelle
Dilanacin
Lanoxin PG
Lanoxicaps
Digacin
Nativelle, Hemigoxine
Lanacordin
Lenoxin
Boehringer, Digoxina
Digoxina Boehringer
Lanoxin-PG
Lanicor
Mapluxin
Digoxine Nativelle
Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
Digoregen
Nativelle, Digoxine
Digitek
See more
See less
|
| prefLabel |
Digoxin
|
| TH |
US
MX
UK
NL
CA
FDA SRS (2014)
ES
INN (19XX)
NLM (2006)
DE
AU
USP (19XX)
BAN (19XX)
FR
IE
See more
See less
|
| notation |
D004077
|
| RR |
20830-75-5 (Digoxin)
|
| DX |
19660101
|
| MN |
D09.408.180.261.436
D04.210.500.155.580.130.688
D04.210.500.155.580.130.500.436
|
| PA |
D004791
D002316
D000889
|
| MMR |
20170524
|
| Mapped from |
See more
See less
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
| subClassOf | |
| Semantic type UMLS property | |
| Inverse of RB |
73K4184T59
0
|
| LT |
TRD
|
| DC |
1
|
| MDA |
19990101
|
| type | |
| tui |
T109
T121
|
| cui |
C1569325
C1569326
C1569322
C0701372
C0701373
C0876017
C0012265
C1569327
C1569323
C0699988
C1569328
C1569324
See more
See less
|
| isa | |
| AN |
do not confuse with DIGITOXIN
|
| Inverse of AQ |
See more
See less
|
| TERMUI |
T610948
T610947
T012361
T012360
T610943
T610949
T610945
T610944
T641426
T610941
T610946
T610942
T610940
T012363
T012362
See more
See less
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |